<DOC>
	<DOCNO>NCT01499342</DOCNO>
	<brief_summary>This Belgian prospective multicentre registry evaluate safety performance Sinus-Superflex-Visual stent ( Optimed ) Superficial Femoral Artery ( SFA ) atherosclerotic lesion . Target number 500 patient approximately 11 centre . Patients follow period 2 year .</brief_summary>
	<brief_title>Belgian Prospective Multicentre Registry Evaluate Safety Performance Optimed Stent Superficial Femoral Artery</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Signed informed consent Stenosis ( &gt; 75 % ) occlusion superficial femoral artery ( lesion 3 cm distal Hunter 's canal 4 cm proximal patella ) TASC II ( 2007 ) type A , B C lesion Target vessel diameter 4.5 7 mm Debilitating claudication critical limb ischemia ( Rutherford 2 5 ) At least 1 outflow vessel ankle Patient least 18 year old Life expectancy &gt; 2 year Patient compliant request followup visit No inform consent Rutherford 6 TASC II type D lesion Patient 18 year old Patient pregnant Acute ischemia Patient compliant request followup visit Unable cross target lesion guidewire Patient allergic nickeltitanium Presence aneurysm SFA</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Stent</keyword>
	<keyword>Atherosclerotic occlusive disease</keyword>
	<keyword>Peripheral arterial disease</keyword>
	<keyword>Superficial femoral artery</keyword>
	<keyword>SFA</keyword>
</DOC>